The genetic sonogram: Its use in the detection of chromosomal abnormalities in fetuses of women of advanced maternal age

Prenatal Diagnosis

Volumn 21, Issue 1, 2001, Pages 40-45

  DeVore, Greggory R ^a,b  

^a Alfigen Inc   (United States)

^b NONE   (United States)

Author keywords

Amniocentesis; Congenital heart defects; Genetic ultrasound; Trisomy 21

Indexed keywords

AMNIOCENTESIS; ANEUPLOIDY; ARTICLE; CHROMOSOME ABERRATION; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DIAGNOSTIC ERROR; DOPPLER ECHOCARDIOGRAPHY; FETUS; FETUS ECHOGRAPHY; HEART VENTRICLE SEPTUM DEFECT; HUMAN; MATERNAL AGE; PERICARDIAL EFFUSION; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; TRICUSPID VALVE REGURGITATION; TRISOMY 13; TRISOMY 18; TRISOMY 21;

ABNORMALITIES; ADULT; AMNIOCENTESIS; CARDIOVASCULAR SYSTEM; CHROMOSOME ABERRATIONS; FALSE POSITIVE REACTIONS; FEMALE; GENE DELETION; GESTATIONAL AGE; HEART DEFECTS, CONGENITAL; HUMANS; KARYOTYPING; MATERNAL AGE; PREGNANCY; PREGNANCY, HIGH-RISK; SEX CHROMOSOME ABERRATIONS; TRISOMY; ULTRASONOGRAPHY, PRENATAL;

EID: 0035143675     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0223(200101)21:1<40::AID-PD980>3.0.CO;2-U     Document Type: Article

References (30)

1. An alternative for women initially declining genetic amniocentesis: Individual Down syndrome odds on the basis of maternal age and multiple ultrasonographic markers
2. Gestational age standardized nuchal thickness values for estimating mid-trimester Down's syndrome risk
3. A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol
4. Subtle ultrasonographic anomalies: Do they improve the Down syndrome detection rate?
5. Color Doppler examination of the outflow tracts of the fetal heart: A technique for identification of cardiovascular malformations
6. The association between an abnormal nuchal skin fold, trisomy 21, and ultrasound abnormalities identified during the second trimester of pregnancy
7. The use of color Doppler ultrasound to identify fetuses at increased risk for trisomy 21: An alternative for high-risk patients who decline genetic amniocentesis
8. Color Doppler identification of a pericardial effusion in the fetus
9. Fetal echocardiography. VII. Doppler color flow mapping: A new technique for the diagnosis of congenital heart disease
10. Fetal echocardiography: Factors that influence imaging of the fetal heart during the second trimester of pregnancy
11. Fetal echocardiography IV: M-mode assessment of ventricular size and contractility during the second and third trimesters of pregnancy in the normal fetus
12. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels
13. Natural history of trisomy 18
14. Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: Experience of a regional programme
15. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening
16. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities
17. Alteration in age-specific risks for chromosomal trisomy by maternal serum alpha-fetoprotein and human chorionic gonadotropin screening
18. Can the presumed risk of autosomal trisomy be decreased in fetuses of older women following a normal sonogram?
19. Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers
20. Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin
21. Maternal serum alpha-fetoprotein screening for chromosomal abnormalities: A prospective study in women aged 35 and older
22. X-Linked diseases and disorders of the sex chromosomes
23. A maternal serum screen for trisomy 18: An extension of maternal serum screening for Down syndrome
24. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women
25. Best second trimester sonographic markers for the detection of trisomy 21
26. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography